Clinical outcomes following CAR T-cell therapy in relapsed or refractory multiple myeloma patients with baseline renal dysfunction: A TriNetX analysis
Department
Internal Medicine
Document Type
Conference Proceeding
Publication Title
Journal of Clinical Oncology
Conference Name
American Society of Clinical Oncology (ASCO) Annual Meeting
Conference Date
2026-05-29 - 2026-06-02
First Page
7539
DOI
10.1200/JCO.2026.44.16_suppl.7539
Volume
44
Issue
16_suppl
Publication Date
6-1-2026
Recommended Citation
Manshahia, P. S., Ardeshna-Chovatiya, J., Jani, I., Sanjeevi, A., Pasnoor, D. S., Khamis, A., Singh, J., & Kota, V. (2026). Clinical outcomes following CAR T-cell therapy in relapsed or refractory multiple myeloma patients with baseline renal dysfunction: A TriNetX analysis. Journal of Clinical Oncology, 44 (16_suppl), 7539. https://doi.org/10.1200/JCO.2026.44.16_suppl.7539
COinS